Evidence map›Paper›PMID 33184713›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Prevalence of ethical dilemmas in advanced cancer patients (secondary analysis of the PALCOM study).

Albert Tuca, Margarita Viladot, Carmen Barrera, Manoli Chicote, Irene Casablancas, Claudia Cruz, Elena Font, Javier Marco-Hernández, Joan Padrosa, Anais Pascual and 2 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Albert TucaHospital Clínic de Barcelona, Barcelona, Spain. ATUCA@clinic.cat.ORCID https://orcid.org/0000-0002-4633-5856
Margarita ViladotHospital Clínic de Barcelona, Barcelona, Spain.
Carmen BarreraHospital Clínic de Barcelona, Barcelona, Spain.
Manoli ChicoteHospital Clínic de Barcelona, Barcelona, Spain.
Irene CasablancasHospital Clínic de Barcelona, Barcelona, Spain.
Claudia CruzHospital Clínic de Barcelona, Barcelona, Spain.
Elena FontHospital Clínic de Barcelona, Barcelona, Spain.
Javier Marco-HernándezHospital Clínic de Barcelona, Barcelona, Spain.
Joan PadrosaHospital Clínic de Barcelona, Barcelona, Spain.
Anais PascualHospital Clínic de Barcelona, Barcelona, Spain.
Núria CodorniuFundación Atención a la Dependencia Sant Joan de Deu, Barcelona, Spain.
Begoña RománFaculty of Philosophy of the University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-6090-0172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe main aim of this study was to determine the prevalence of ethical dilemmas in the end-of-life process in advanced cancer patients.

methodsWe carried out a multicenter, cross-sectional, observational, prospective study in a cohort of cancer patients whose life expectancy was ≤ 6 months. We recorded sociodemographic characteristics, diagnosis of cancer, symptom burden, cognitive and functional status, emotional impact, and sociofamilial risk factors. The main outcome measure was the detection of ethical dilemmas, based on the following definition: conflict in decision-making during the end-of-life process that involves the need to choose between morally acceptable opposing options, where none is clearly preferable to another.

resultsWe included 324 patients (mean age, 69 years; 58% men). We identified 117 dilemmas in 90 patients (27.8%). The dilemmas detected were as follows: (a) conflicts of information (adaptive denial, conspiracy of silence, information exceeding patient's desired limit), 15.7%; (b) discrepancies in proportionality (discussion on futility, rejection of treatment, withdrawal of life support measures), 16.7%; (c) unrealistic expectations about the outcome of clinical trials, 2.5%; and (d) request for euthanasia or medically assisted suicide, 1.2%. We observed a greater prevalence of ethical dilemmas in men, in patients receiving active cancer treatment, and in patients with emotional distress (p < 0.05).

conclusionsThe prevalence of ethical dilemmas during the end-of-life process in cancer patients is relevant. Most dilemmas were associated directly or indirectly with respect for patient autonomy. In this context, the communication skills of the health professionals and advanced care planning take on a key role.

Indexed as

AgedCross-Sectional StudiesDecision MakingFemaleHumansMaleMoralsNeoplasmsPrevalenceProspective StudiesCancerConflictDecision-makingEnd of lifeEthical dilemma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.